A New Era of Treatment for Rosacea: My Taiwan
Experience
Jeng-Hsien
LIN, Dr. LIN’s Dermatological Clinic, TAIWAN
Rosacea is a very complicated skin problem
which is difficult to cope with. Even now, the drug that can result in quick
improvement and long-term stabilization without recurrence is still lacking.
The clinical subtypes include: erythrotelangiectatic rosacea (ETR),
papulopustular rosacea(PPR), rhinophyma, and ocular rosacea. Among them, the
former two types are the most common.
The clinical symptoms of rosacea is
versatile, including persistent erythema on the cheeks, which is easily
worsened by various exacerbating factors, such as sun exposure, excitement,
nervousness, hot or spicy food, or alcoholic beverages. Recently, the treatment
plan has shifted from targeting the different subtypes to aiming at different
phenotypes.
In recent years, many studies have shown
that the pathogenesis of rosacea is very sophisticated, including genes, immune
systems, vascular hyper-responsiveness, nervous systems, skin barrier
impairment, and demodex. The role of demodex in rosacea has been debated for a
long time because they are the normal flora in human skin.
In Taiwan, Dr. Hui-Peng Huang, a rosacea expert,
has been engaged in the relationship between rosacea and demodex for more than five
years. He published two novel methods to more accurately exam the demodex
density in ETR and PPR. The first one is “superficial needle-scraping method” when
pustules are available.1 The second one is “thumb squeezing method”
when there is no pustules.2 These two easier methods not only have
much higher examination sensitivity (above 90%) when compared with previous standardized
skin surface biopsy, but also confirm the pivotal role of demodex in pathogenesis
of rosacea.
The recent advent of topical parasiticidal ivermectin
ointment, in conjunction with the above-mentioned examination methods, has
opened a new era in the diagnosis and treatment of rosacea. In fact, based on my
experience of using topical ivermectin in the past two years, if the patients
with demodex density can be correctly screened, the papules and pustules of rosacea
can usually subside quickly within one month, and persistent erythema will also
improve a lot (Figure 1). The demodex density can be lowered within normal limit In
two to four months, and the clinical symptoms can be restored to a fairly good
status. Moreover, the recurrence rate is much lower than the patients treated
with traditional oral doxycycline and topical metronidazole gel. This is a huge
leap forward for the traditional stereotype that rosacea is a disease with high
recurrent rate.
A recent paper also found that the
exacerbation of rosacea of some patients after intense pulsed light or pulse
dye laser may also be related to demodex infection.3 It is presumed
that when high-energy light penetrates the skin, demodex mites will be killed.
The chitin exoskeletons and the bacteria or substances in the bodies of demodex
can stimulate strong inflammation, which in turn causes flushing, erythema,
papules and pustules, indicating worsening of rosacea. All these prove the
importance of demodex in the pathogenesis of rosacea.
In conclusion, the great frustrations
experienced by physicians in the treatment of rosacea in the past have
undergone tremendous changes under the establishment of new concepts, the use
of new examination methods, and the advent of new drugs. Combining the control
of other pathogenic factors, treatment of rosacea is no longer so difficult,
and the quality of life of patients can also be improved a lot.
![]() |
Figure 1: Without any steroids, the topical anti-parasite ivermectin ointment can quickly improve severe rosacea in a few weeks. |
References:
1.
A new superficial
needle-scraping method for assessing Demodex density in papulopustular rosacea.
J Cosmet Dermatol. 2019 Jul 25. doi: 10.1111/jocd.13082.
2.
Thumbnail-squeezing Method: An
Effective Method for Assessing Demodex Density in Rosacea. J Eur Acad
Dermatol Venereol. 2020 Mar 3. doi: 10.1111/jdv. 16321.
3.
Latent Demodex infection
contributes to intense pulsed light aggravated rosacea: cases serial. J
Cosmet Laser Ther. 2019;21(3):163-165.
Comments
Post a Comment